PROWESS Trial
(Last Updated - 12/12/2010)

"Efficacy And Safety Of Recombinant Human Activated Protein C For Severe Sepsis"
     NEJM: 3/8/2001 - Volume 344(10): Pages 699-709.

Serious bleeding: 3.5% (during infusion period) vs. 2.0% (placebo)
Serious Bleeding Defined As:
     -ICH
     -Life-threatening bleed
     -Any bleed requiring 3 units PRBC's

NNH: 1/66


==============================================
References: